These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34096837)

  • 21. Safety Profile of Antipsychotic Drugs: Analysis Based on a Provincial Spontaneous Reporting Systems Database.
    Guo K; Feng Z; Chen S; Yan Z; Jiao Z; Feng D
    Front Pharmacol; 2022; 13():848472. PubMed ID: 35355731
    [No Abstract]   [Full Text] [Related]  

  • 22. Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance programme.
    Letmaier M; Grohmann R; Kren C; Toto S; Bleich S; Engel R; Gary T; Papageorgiou K; Konstantinidis A; Holl AK; Painold A; Kasper S
    World J Biol Psychiatry; 2018 Apr; 19(3):175-186. PubMed ID: 28112047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017.
    Seifert J; Führmann F; Reinhard MA; Engel RR; Bernegger X; Bleich S; Stübner S; Rüther E; Toto S; Grohmann R; Sieberer M; Greil W
    J Neural Transm (Vienna); 2021 Jun; 128(6):827-843. PubMed ID: 33977402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical adverse drug reactions: descriptive analysis of French reports.
    Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study.
    Druschky K; Bleich S; Grohmann R; Engel RR; Kleimann A; Stübner S; Greil W; Toto S
    Eur Arch Psychiatry Clin Neurosci; 2018 Mar; 268(2):191-208. PubMed ID: 28766129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug Administration.
    Liu XI; Schuette P; Burckart GJ; Green DJ; La J; Burnham JM; Rakhmanina N; Robb A; Huang SM; van den Anker JN
    J Pediatr; 2019 May; 208():236-242.e3. PubMed ID: 30679050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal and life-threatening ADRs associated with paliperidone palmitate: an observational study in the French pharmacovigilance database.
    Boels D; Mahé J; Olry A; Citterio-Quentin A; Moragny J; Jolliet P
    Clin Toxicol (Phila); 2021 Sep; 59(9):786-793. PubMed ID: 33555955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe and uncommon involuntary movement disorders due to psychotropic drugs.
    Stübner S; Rustenbeck E; Grohmann R; Wagner G; Engel R; Neundörfer G; Möller HJ; Hippius H; Rüther E
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S54-64. PubMed ID: 15052515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperglycemia associated with antipsychotic treatment in a multicenter drug safety project.
    Kropp S; Grohmann R; Hauser U; Rüther E; Degner D
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S79-83. PubMed ID: 15052518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The AMSP drug safety program: methods and global results.
    Grohmann R; Engel RR; Rüther E; Hippius H
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S4-11. PubMed ID: 15052509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and Correlates of Acute Dystonic Reactions After Antipsychotic Initiation in 441 Children and Adolescents.
    Tural Hesapcioglu S; Ceylan MF; Kandemir G; Kasak M; Sen CP; Correll CU
    J Child Adolesc Psychopharmacol; 2020 Jul; 30(6):366-375. PubMed ID: 32255662
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversible Amisulpride-induced Elevation of Creatine Kinase (CK): A Case Series from the German AMSP Pharmacovigilance Project.
    Laoutidis ZG; Konstantinidis A; Grohmann R; Luckhaus C; Mobascher J; Cordes J
    Pharmacopsychiatry; 2015 Jul; 48(4-5):178-81. PubMed ID: 25984709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
    Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM
    Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - A drug surveillance report from German-speaking countries.
    Winkler D; Grohmann R; Friedrich ME; Toto S; Bleich S; Seifert J; Konstantinidis A; Shariat SF; Kasper S; Pjrek E
    J Psychiatr Res; 2021 Dec; 144():412-420. PubMed ID: 34741839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians.
    Naber D; Lambert M
    CNS Drugs; 2009 Aug; 23(8):649-59. PubMed ID: 19594194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological Adverse Effects of Antipsychotics in Children and Adolescents.
    Garcia-Amador M; Merchán-Naranjo J; Tapia C; Moreno C; Castro-Fornieles J; Baeza I; de la Serna E; Alda JA; Muñoz D; Andrés Nestares P; Cantarero CM; Arango C
    J Clin Psychopharmacol; 2015 Dec; 35(6):686-93. PubMed ID: 26505569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.